The £8.50 bar of soap used by the King
Last week a bar of soap arrived on my desk. So far, so boring. But this soap was shaped like a lemon – complete with a convincingly grainy texture – and smelt exactly how a lemon should smell: zesty and fresh.
And the brand? It was the £8.50 Lemon Soap from Bronnley, a brand that has just received a royal warrant from King Charles III as supplier of soap.
It turns out soap bars are in fashion again, after years of plastic-pump hand washes reigning supreme. In fact, it is five years ago this month since the start of the first Covid lockdown and the resultant boom in liquid washes and sanitisers.
But now we're back on soap, in a big way: the global bar soap market is estimated to grow by around £7 billion from 2024 to 2028, according to market research company Technavio.
There's something so satisfying about how well a bar of soap lathers up in your hands, plus the newer formulations don't feel skin-stripping – which I've always found very off-putting – and are mostly very moisturising.
For a product that was originally created in 1892, the Bronnley Lemon Soap has stood the test of time, and it is still produced in the UK in small batches – a rarity nowadays. It's also incredibly popular: one bar of the brand's soap is sold every four minutes.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wales Online
6 hours ago
- Wales Online
Company linked to Tory Peer Baroness Mone should pay back £121m for ‘faulty' PPE, High Court hears
Company linked to Tory Peer Baroness Mone should pay back £121m for 'faulty' PPE, High Court hears PPE Medpro is being sued for an alleged breach of contract over the supply of PPE during the Covid pandemic, with the Government claiming the gowns were unusable The company in court is linked to Baroness Mone (Image: PA Archive/PA Images ) A company linked to Tory peer Michelle Mone should pay back more than £121 million for breaching a Government contract for 25 million surgical gowns during the coronavirus pandemic, the High Court has heard. The Department of Health and Social Care (DHSC) is suing PPE Medpro for allegedly breaching a deal for the gowns, with lawyers for the Government telling the court they were "faulty" because they were not sterile. The company, a consortium led by Baroness Mone's husband, businessman Doug Barrowman, was awarded Government contracts by the former Conservative administration to supply PPE during the pandemic, after she recommended it to ministers. Any wrongdoing has been denied. For our free daily briefing on the biggest issues facing the nation, sign up to the Wales Matters newsletter here The Government is seeking to recover the costs of the contract, as well as the costs of transporting and storing the items, which amount to an additional £8,648,691. PPE Medpro said it "categorically denies" breaching the contract, and its lawyers claimed the company had been "singled out for unfair treatment". Opening the trial on Wednesday, Paul Stanley KC, for the DHSC, said: "This case is simply about whether 25 million surgical gowns provided by PPE Medpro were faulty. Article continues below "It is, in short, a technical case about detailed legal and industry standards that apply to sterile gowns." Mr Stanley said in written submissions the "initial contact with Medpro came through Baroness Mone", with discussions about the contract then going through one of the company's directors, Anthony Page. Baroness Mone remained "active throughout" the negotiations, Mr Stanley said, with the peer stating Mr Barrowman had "years of experience in manufacturing, procurement and management of supply chains". But he told the court Baroness Mone's communications were "not part of this case", which was "simply about compliance". He said: "The department does not allege anything improper happened, and we are not concerned with any profits made by anybody." In court documents from May this year, the DHSC said the gowns were delivered to the UK in 72 lots between August and October, 2020, with £121,999,219.20 paid to PPE Medpro between July and August that year. The department rejected the gowns in December, 2020, and told the company it would have to repay the money, but this has not happened and the gowns remain in storage, unable to be used. In written submissions for trial, Mr Stanley said 99.9999% of the gowns should have been sterile under the terms of the contract, equating to one in a million being unusable. The DHSC claims the contract also specified PPE Medpro had to sterilise the gowns using a "validated process", attested by CE marking, which indicates a product has met certain medical standards. He said "none of those things happened", with no validated sterilisation process being followed, and the gowns supplied with invalid CE marking. He continued that 140 gowns were later tested for sterility, with 103 failing. He said: "Whatever was done to sterilise the gowns had not achieved its purpose, because more than one in a million of them was contaminated when delivered. "On that basis, DHSC was entitled to reject the gowns, or is entitled to damages, which amount to the full price and storage costs." In his written submissions, Charles Samek KC, for PPE Medpro, said the "only plausible reason" for the gowns becoming contaminated was due to "the transport and storage conditions or events to which the gowns were subject", after they had been delivered to the DHSC. He added the testing did not happen until several months after the gowns were rejected, and the samples selected were not "representative of the whole population", meaning "no proper conclusions may be drawn". He said the DHSC's claim was "contrived and opportunistic" and PPE Medpro had been "made the 'fall guy' for a catalogue of failures and errors" by the department. He said: "It has perhaps been singled out because of the high profiles of those said to be associated with PPE Medpro, and/or because it is perceived to be a supplier with financial resources behind it. "In reality, an archetypal case of 'buyer's remorse', where DHSC simply seeks to get out of a bargain it wished it never entered into, left, as it is, with over £8 billion of purchased and unused PPE as a result of an untrammelled and uncontrolled buying spree with taxpayers' money." He also said there was a "delicious irony" that Baroness Mone was mentioned in the DHSC's written submissions, when she had "zero relevance to the contractual issues in this case". Neither Baroness Mone nor Mr Barrowman is due to give evidence in the trial, and did not attend the first day of the hearing on Wednesday. A PPE Medpro spokesperson said the company "categorically denies breaching its obligations" and will "robustly defend" the claim. Article continues below The trial before Mrs Justice Cockerill is due to last five weeks, with a judgment expected in writing at a later date.
Fashion United
9 hours ago
- Fashion United
Pinko returns to profitability following strategic restructuring and new leadership
After navigating several challenging years, Italian womenswear brand PINKO has successfully returned to profitability in the first quarter of 2025. This marks a significant achievement in its ongoing transformation, driven by a strategic overhaul and new leadership. The company, founded in 1986 by Pietro Negra and Cristina Rubini, reported Q1 sales exceeding 70 million euros and a positive EBITDA shift of 6 million euros, moving from -1.2 million euros to +5 million euros year-on-year. This turnaround comes as PINKO works to emerge from Italy's Composizione negoziata della crisi, a negotiated debt settlement procedure. Chairman Pietro Negra described it as a "real turning point," emphasizing a prudent, sustainable business plan designed to generate cash flow starting this year. A new phase under CEO Laura Manelli The arrival of CEO Laura Manelli in March 2025 signaled a decisive shift for PINKO. With extensive experience at leading fashion houses such as Armani, Versace, Fendi, and Sergio Rossi, Manelli brings a strong background in financial oversight and fashion operations. Under her leadership, PINKO has concentrated on redefining its business model, streamlining operations, and realigning with core brand values. "We prefer not to call it a relaunch," Manelli stated. "There is untapped potential in the brand. These results confirm that our new approach is working." She underscored the company's strengths in brand recognition and customer loyalty, attributing the recent progress to employee commitment and the new management team's direction. Lessons learned from overexpansion PINKO's current position follows a period of rapid expansion and financial strain. After growing revenue from 197 million in 2019 to 303 million euros in 2022, the company embarked on an ambitious international strategy targeting 500 million euros in turnover. However, significant investments in China and the US underperformed, leading to liquidity issues and a debt load exceeding 100 million euros by late 2023. "The post-Covid growth wave misled us," Negra admitted. "We invested too fast, especially in China, where market dynamics shifted rapidly. Our mistake wasn't going to China – it was going too fast." The restructuring blueprint To regain financial stability, PINKO implemented comprehensive restructuring measures, including closing underperforming stores, cutting operational costs, resizing the company, and simplifying its governance. The plan has been submitted to banks for final approval and is expected to conclude the debt resolution process by mid-year. Both Negra and Manelli emphasize that the crisis was financial, not a crisis of brand identity. "This was a financial crisis, not a crisis of image," Manelli noted. The brand's appeal remains intact, and current efforts are focused on refining market positioning and improving operational efficiency. Future outlook: Strategic recalibration Positioned firmly in the 'entry-to-luxury' segment, PINKO is recalibrating its international strategy with a more selective and geographically cautious approach. A new partnership with Lima Commercial Management in Shanghai, signed in February 2025, exemplifies this shift towards sustainable growth in China. Domestically and internationally, PINKO is also deliberately moving away from the post-pandemic pricing surge observed across the luxury sector. "We're lowering our prices," Negra stated. "Our aim is to offer the best value for money while maintaining our aspirational brand presence." With strong Q1 figures, a refined strategy, and new leadership at the helm, PINKO appears to be transitioning beyond crisis towards a more measured and resilient future.
Sky News
10 hours ago
- Sky News
Spending review 2025: The key announcements
Rachel Reeves is setting out her spending review in the House of Commons. It outlines how much funding individual government departments will receive over the next three years and state infrastructure investment for the next four years. The last spending review took place during the COVID-19 pandemic, and before that, in 2015. Here's what's been announced so far - please refresh this page for updates. Defence A major recipient of funds is the Ministry of Defence. Defence spending will rise from 2.3% of gross domestic product (GDP) to 2.6% by 2027. An £11bn uplift and a £600 million uplift for security and intelligence agencies. Within that there'll be £4.5bn of investment in munitions made in Glasgow and more than £6bn to upgrade to nuclear submarine production. Border security The chancellor goes onto border security, where she says funding will increase with up to £280m more per year by the end of the spending review for the new Border Security Command. She said the Home Secretary Yvette Cooper will end the costly use of hotels to house asylum seekers by 2029. The chancellor says funding she has announced today, including from the transformation fund, will also cut the asylum backlog, see more appeal cases heard and "return people who have no right to be here". This will save the taxpayer £1bn a year, she says. Energy The biggest nuclear building programme for half a century has been announced with £14.2bn being poured into the Sizewell C nuclear power station on the Suffolk coastline. A total of £14bn will go to the Sizewell C nuclear power plant. Another £2.5bn will be invested in a new small modular reactor programme. A commitment to nuclear was reiterated, with £30bn allocated. Science and technology Moving on from energy and infrastructure, the chancellor says she wants the country's high tech industries in Britain to continue to lead the world in the years to come. Research and development funding will go to a record high of £22bn a year by the end of the spending period. The government's artificial intelligence action plan will receive £2bn. Housing Government funding of social and affordable housing has been allocated £39bn. She says she is providing an additional £10bn for financial investments, including to be delivered through Homes England, to help unlock hundreds of thousands more homes.
